Overview

Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients

Status:
Active, not recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
Purpose of the study : To evaluate the antitumoral effect of two therapeutic procedures and to evaluate their respective toxicity on the CNS.
Phase:
Phase 2
Details
Lead Sponsor:
Institut Curie
Collaborators:
Amgen
Hoffmann-La Roche
Ministry of Health, France
Pierre Fabre Laboratories
Treatments:
Busulfan
Carmustine
Cyclophosphamide
Cytarabine
Etoposide
Methotrexate
Prednisone
Thiotepa